-
1
-
-
0013591652
-
Principles of therapy of tuberculosis
-
W. N. Rom and S. Garay, editors. Little Brown, Boston
-
Schluger, N., T. Harkin, and W. Rom. 1996. Principles of therapy of tuberculosis. In W. N. Rom and S. Garay, editors. Tuberculosis. Little Brown, Boston.
-
(1996)
Tuberculosis
-
-
Schluger, N.1
Harkin, T.2
Rom, W.3
-
2
-
-
0030766237
-
Trends in drug-resistant tuberculosis in the United States, 1993-1996
-
Moore, M., I. M. Onorato, E. McCray, and K. G. Castro. 1997. Trends in drug-resistant tuberculosis in the United States, 1993-1996. J.A.M.A. 278:833-837.
-
(1997)
J.A.M.A.
, vol.278
, pp. 833-837
-
-
Moore, M.1
Onorato, I.M.2
McCray, E.3
Castro, K.G.4
-
3
-
-
0027411682
-
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
-
Small, P. M., R. W. Shafer, P. C. Hopewell, S. P. Singh, M. J. Murphy, E. Desmond, M. F. Sierra, and G. K. Schoolnik. 1993. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N. Engl. J. Med. 328:1137-1144.
-
(1993)
N. Engl. J. Med.
, vol.328
, pp. 1137-1144
-
-
Small, P.M.1
Shafer, R.W.2
Hopewell, P.C.3
Singh, S.P.4
Murphy, M.J.5
Desmond, E.6
Sierra, M.F.7
Schoolnik, G.K.8
-
4
-
-
0029999521
-
Selective malabsorption and the origin of mono-rifampin-resistant Mycobacterium tuberculosis
-
Perlman, D. C., and N. Salomon. 1996. Selective malabsorption and the origin of mono-rifampin-resistant Mycobacterium tuberculosis (letter). Am. J. Respir. Crit. Care Med. 154:1213.
-
(1996)
Am. J. Respir. Crit. Care Med.
, vol.154
, pp. 1213
-
-
Perlman, D.C.1
Salomon, N.2
-
5
-
-
0031886212
-
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis
-
Mitchison, D. A. 1998. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int. J. Tuberc. Lung Dis. 2:10-15.
-
(1998)
Int. J. Tuberc. Lung Dis.
, vol.2
, pp. 10-15
-
-
Mitchison, D.A.1
-
6
-
-
0027272060
-
Pitfalls in the care of patients with tuberculosis: Common errors and their association with the acquisition of drug resistance
-
Mahmoudi, A., and M. D. Iseman. 1993. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. J.A.M.A. 270:65-68.
-
(1993)
J.A.M.A.
, vol.270
, pp. 65-68
-
-
Mahmoudi, A.1
Iseman, M.D.2
-
7
-
-
0030831049
-
Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis
-
March, F., X. Garriga, P. Rodriguez, C. Moreno, M. Garrigo, P. Coll, and G. Prats. 1997. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis. Clin. Infect. Dis. 25:1044-1047.
-
(1997)
Clin. Infect. Dis.
, vol.25
, pp. 1044-1047
-
-
March, F.1
Garriga, X.2
Rodriguez, P.3
Moreno, C.4
Garrigo, M.5
Coll, P.6
Prats, G.7
-
8
-
-
0027448435
-
The emergence of drug-resistant tuberculosis in New York City
-
Frieden, T. R., T. Sterling, A. Pablos-Mendez, J. O. Kilburn, G. M. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526.
-
(1993)
N. Engl. J. Med.
, vol.328
, pp. 521-526
-
-
Frieden, T.R.1
Sterling, T.2
Pablos-Mendez, A.3
Kilburn, J.O.4
Cauthen, G.M.5
Dooley, S.W.6
-
9
-
-
0029995436
-
Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis
-
Bishai, W. R., N. M. H. Graham, S. Harrington, C. Page, K. Moore-Rice, N. Hooper, and R. E. Chaisson. 1996. Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. N. Engl. J. Med. 334:1573-1576.
-
(1996)
N. Engl. J. Med.
, vol.334
, pp. 1573-1576
-
-
Bishai, W.R.1
Graham, N.M.H.2
Harrington, S.3
Page, C.4
Moore-Rice, K.5
Hooper, N.6
Chaisson, R.E.7
-
10
-
-
9044254531
-
Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS
-
Lutfey, M., P. Della-Latta, V. Kapur, L. A. Palumbo, D. Gurner, G. Stotzky, K. Brudney, J. Dobkin, A. Moss, J. M. Musser, and B. N. Kreiswirth. 1996. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am. J. Respir. Crit. Care Med. 153:837-840.
-
(1996)
Am. J. Respir. Crit. Care Med.
, vol.153
, pp. 837-840
-
-
Lutfey, M.1
Della-Latta, P.2
Kapur, V.3
Palumbo, L.A.4
Gurner, D.5
Stotzky, G.6
Brudney, K.7
Dobkin, J.8
Moss, A.9
Musser, J.M.10
Kreiswirth, B.N.11
-
11
-
-
0029082991
-
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis
-
Nolan, C. M., D. L. Williams, M. D. Cave, K. D. Eisenach, H. el-Hajj, T. M. Hooton, R. L. Thompson, and S. V. Goldberg. 1995. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am. J. Respir. Crit. Care Med. 152:1067-1071.
-
(1995)
Am. J. Respir. Crit. Care Med.
, vol.152
, pp. 1067-1071
-
-
Nolan, C.M.1
Williams, D.L.2
Cave, M.D.3
Eisenach, K.D.4
El-Hajj, H.5
Hooton, T.M.6
Thompson, R.L.7
Goldberg, S.V.8
-
12
-
-
0031467418
-
Rifampin-monoresistant tuberculosis in New York City, 1993-1994
-
Munsiff, S. S., S. Joseph, A. Ebrahimzadeh, and T. R. Frieden. 1997. Rifampin-monoresistant tuberculosis in New York City, 1993-1994. Clin. Infect. Dis. 25:1465-1467.
-
(1997)
Clin. Infect. Dis.
, vol.25
, pp. 1465-1467
-
-
Munsiff, S.S.1
Joseph, S.2
Ebrahimzadeh, A.3
Frieden, T.R.4
-
13
-
-
0016839067
-
Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong
-
Hong Kong Chest Service/British Medical Research Council. 1975. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. Tubercle 56:81-96.
-
(1975)
Tubercle
, vol.56
, pp. 81-96
-
-
-
14
-
-
0030058146
-
Outcome of MDR-TB patients, 1983-1993: Prolonged survival with appropriate therapy
-
Park, M. M., A. L. Davis, N. W. Schluger, H. Cohen, and W. N. Rom. 1996. Outcome of MDR-TB patients, 1983-1993: prolonged survival with appropriate therapy. Am. J. Respir. Crit. Care Med. 153:317-324.
-
(1996)
Am. J. Respir. Crit. Care Med.
, vol.153
, pp. 317-324
-
-
Park, M.M.1
Davis, A.L.2
Schluger, N.W.3
Cohen, H.4
Rom, W.N.5
-
15
-
-
0024600645
-
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
-
Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Klein, A. T. Walker, and G. H. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320:545-550
-
(1989)
N. Engl. J. Med.
, vol.320
, pp. 545-550
-
-
Selwyn, P.A.1
Hartel, D.2
Lewis, V.A.3
Schoenbaum, E.E.4
Vermund, S.H.5
Klein, R.S.6
Walker, A.T.7
Friedland, G.H.8
-
16
-
-
0029841198
-
Low antituberculosis drug concentrations in patients with AIDS
-
Peloquin, C. A., A. T. Nitta, W. J. Burman, K. F. Brudney, J. R. Miranda-Massari, M. E. McGuinness, S. E. Berning, and G. T. Gerena. 1996. Low antituberculosis drug concentrations in patients with AIDS. Ann. Pharmacother. 30:919-925.
-
(1996)
Ann. Pharmacother.
, vol.30
, pp. 919-925
-
-
Peloquin, C.A.1
Nitta, A.T.2
Burman, W.J.3
Brudney, K.F.4
Miranda-Massari, J.R.5
McGuinness, M.E.6
Berning, S.E.7
Gerena, G.T.8
-
17
-
-
0030601568
-
Clinical update: Impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin
-
Center for Disease Control. 1996. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin. Morbid. Mortal. Wkly. Rep. 45:921-925.
-
(1996)
Morbid. Mortal. Wkly. Rep.
, vol.45
, pp. 921-925
-
-
-
18
-
-
0013564466
-
Update on U.S. Public Health Service (USPHS) study 22: A trial of once weekly isoniazid and rifapentine in the continuation phase of TB treatment
-
Vernon, A., A. Khan, L. Bozeman, and Y. Wang. 1998. Update on U.S. Public Health Service (USPHS) study 22: a trial of once weekly isoniazid and rifapentine in the continuation phase of TB treatment (abstract). Am. J. Respir. Crit. Care Med. 157:A467.
-
(1998)
Am. J. Respir. Crit. Care Med.
, vol.157
-
-
Vernon, A.1
Khan, A.2
Bozeman, L.3
Wang, Y.4
-
19
-
-
0031914741
-
Population dynamics of tuberculosis treatment: Mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance
-
Lipstich, M., and B. R. Levin. 1998. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Int. J. Tuberc. Lung Dis. 2:187-199.
-
(1998)
Int. J. Tuberc. Lung Dis.
, vol.2
, pp. 187-199
-
-
Lipstich, M.1
Levin, B.R.2
-
20
-
-
17444442465
-
Risk factors for rifampin mono-resistant tuberculosis
-
Ridzon, R., C. G. Whitney, M. T. McKenna, J. P. Taylor, S. H. Ashkar, A. T. Nitta, S. M. Harvey, S. Valway, C. Woodley, R. Cooksey, and I. M. Onorato. 1998. Risk factors for rifampin mono-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 157:1881-1884.
-
(1998)
Am. J. Respir. Crit. Care Med.
, vol.157
, pp. 1881-1884
-
-
Ridzon, R.1
Whitney, C.G.2
McKenna, M.T.3
Taylor, J.P.4
Ashkar, S.H.5
Nitta, A.T.6
Harvey, S.M.7
Valway, S.8
Woodley, C.9
Cooksey, R.10
Onorato, I.M.11
|